Pharmaceutical News and Articles

Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)

OSAKA, Japan and CAMBRIDGE, Massachusetts, May 4, 2026 Takeda (TSE 4502 NYSE TAK) today announced that TAK-881-3001, a pivotal Phase 2 3 clinical trial in patie

FDA Approves Langlara (insulin glargine-aldy), an Interchangeable Biosimilar to Lantus

ADMA Biologics Announces FDA Approval to Expand the Label for Asceniv to Include Pediatric Immune Compromised Patients Two Years of Age and Older

FDA Approves Dupixent for Chronic Spontaneous Urticaria in Young Children

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of children (aged 2 to 11 years) with chronic spontaneous urticaria (C

50 Large TB Outbreaks Identified in 23 States During 2017 to 2023

Fifty large tuberculosis (TB) outbreaks were identified in 23 states during 2017 to 2023, mainly involving U.S.-born persons, according to research published in

Supreme Court Puts Brakes on Abortion Pill Restrictions

MONDAY, May 4, 2026 The Supreme Court has temporarily stepped in to preserve nationwide access to the abortion pill mifepristone, halting a lower court ruling t

'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes

MONDAY, May 4, 2026 Social media is filled with posts about exercising and clean eating that are meant to inspire folks and encourage healthier habits. But thes

Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use

MONDAY, May 4, 2026 New research is raising alarms about inhalants, which are often portrayed online as harmless while putting teens at real risk. Two new studi

Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds

MONDAY, May 4, 2026 Misinformation is putting more than 16 million Americans at increased risk for skin cancer, a new American Academy of Dermatology (AAD) surv

Patients Wait About 50 Days on Average for First Visit to Neurologist

Wait times for new neurologist appointments are about 50 days on average and vary by sex, neurologic conditions, and insurance type and geographic-level variabl